These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33075814)

  • 1. Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH.
    Sengal A; Velazquez J; Hahne M; Burke TM; Abhyankar H; Reyes R; Olea W; Scull B; Eckstein OS; Bigenwald C; Bollard CM; Yu W; Merad M; McClain KL; Allen CE; Chakraborty R
    Blood; 2021 Apr; 137(13):1777-1791. PubMed ID: 33075814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
    Hogstad B; Berres ML; Chakraborty R; Tang J; Bigenwald C; Serasinghe M; Lim KPH; Lin H; Man TK; Remark R; Baxter S; Kana V; Jordan S; Karoulia Z; Kwan WH; Leboeuf M; Brandt E; Salmon H; McClain K; Poulikakos P; Chipuk J; Mulder WJM; Allen CE; Merad M
    J Exp Med; 2018 Jan; 215(1):319-336. PubMed ID: 29263218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis.
    Jouenne F; Benattia A; Tazi A
    Curr Opin Oncol; 2021 Mar; 33(2):101-109. PubMed ID: 33315630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer.
    Egelston C; Guo W; Yost S; Lee JS; Rose D; Avalos C; Ye J; Frankel P; Schmolze D; Waisman J; Lee P; Yuan Y
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33757987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
    Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
    J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease.
    Abla O
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):386-395. PubMed ID: 38066856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
    Okamoto T; Murata Y; Hasegawa D; Yoshida M; Tanaka D; Ueda T; Hazama D; Oduori OS; Komori S; Takai T; Saito Y; Kotani T; Kosaka Y; Maniwa Y; Matozaki T
    Cancer Sci; 2023 May; 114(5):1871-1881. PubMed ID: 36788737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
    Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
    Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
    Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
    Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Allen CE
    Blood; 2020 Apr; 135(16):1319-1331. PubMed ID: 32106306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of PD-1/PD-L1 immune checkpoint expression in the pathogenesis of musculoskeletal Langerhans cell histiocytosis: A retrospective study.
    Hashimoto K; Nishimura S; Sakata N; Inoue M; Sawada A; Akagi M
    Medicine (Baltimore); 2021 Oct; 100(43):e27650. PubMed ID: 34713856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of CXCR3-CXCR6 + CD4 + T cells in Langerhans cell histiocytosis.
    Tokutsu A; Okada Y; Kurozumi A; Tanaka K; Kubo S; Tanaka Y
    J Bone Miner Metab; 2023 Mar; 41(2):212-219. PubMed ID: 36629910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cell histiocytosis: Version 2021.
    Gulati N; Allen CE
    Hematol Oncol; 2021 Jun; 39 Suppl 1(Suppl 1):15-23. PubMed ID: 34105821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis.
    Gao XM; Li J; Cao XX
    Cell Commun Signal; 2022 Dec; 20(1):195. PubMed ID: 36536400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis.
    Karri V; Lin H; Velazquez J; Batajoo A; Parekh D; Stanton W; Abhyankar H; El-Mallawany NK; Agrusa J; Eckstein O; Gulati N; Schwartz J; Woods-Swafford W; Boyd J; Saha A; Allen CE; McClain KL
    Br J Haematol; 2024 May; 204(5):1882-1887. PubMed ID: 38501390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.